Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Asian J Androl ; 23(4): 409-414, 2021.
Article in English | MEDLINE | ID: mdl-33533737

ABSTRACT

Accurate methods for identifying pelvic lymph node metastasis (LNM) of prostate cancer (PCa) prior to surgery are still lacking. We aimed to investigate the predictive value of peripheral monocyte count (PMC) for LNM of PCa in this study. Two hundred and ninety-eight patients from three centers were divided into a training set (n = 125) and a validation set (n = 173). In the training set, the independent predictors of LNM were analyzed using univariate and multivariate logistic regression analyses, and the optimal cutoff value was calculated by the receiver operating characteristic (ROC) curve. The sensitivity and specificity of the optimal cutoff were authenticated in the validation cohort. Finally, a nomogram based on the PMC was constructed for predicting LNM. Multivariate analyses of the training cohort demonstrated that clinical T stage, preoperative Gleason score, and PMC were independent risk factors for LNM. The subsequent ROC analysis showed that the optimal cutoff value of PMC for diagnosing LNM was 0.405 × 109 l-1 with a sensitivity of 60.0% and a specificity of 67.8%. In the validation set, the optimal cutoff value showed significantly higher sensitivity than that of conventional magnetic resonance imaging (MRI) (0.619 vs 0.238, P < 0.001). The nomogram involving PMC, free prostate-specific antigen (fPSA), clinical T stage, preoperative Gleason score, and monocyte-to-lymphocyte ratio (MLR) was generated, which showed a robust predictive capacity for predicting LNM before the operation. Our results indicated that PMC as a single agent, or combined with other clinical parameters, showed a robust predictive capacity for LNM in PCa. It can be employed as a complementary factor for the decision of whether to conduct pelvic lymph node dissection.


Subject(s)
Lymphatic Metastasis/diagnosis , Monocytes/cytology , Nomograms , Prostatic Neoplasms/complications , Aged , Aged, 80 and over , China , Humans , Logistic Models , Lymph Nodes/pathology , Lymphatic Metastasis/physiopathology , Male , Middle Aged , Prostatectomy/methods , Prostatic Neoplasms/physiopathology
2.
BMC Med Inform Decis Mak ; 20(1): 337, 2020 12 14.
Article in English | MEDLINE | ID: mdl-33317510

ABSTRACT

BACKGROUND: Different from adult clinical stage I (CS1) testicular cancer, surveillance has been recommended for CS1 pediatric testicular cancer. However, among high-risk children, more than 50% suffer a relapse and progression during surveillance, and adjuvant chemotherapy needs to be administered. Risk-adapted treatment might reduce chemotherapy exposure among these children. METHODS: A decision model was designed and calculated using TreeAge Pro 2011 software. Clinical utilities such as the relapse rates of different groups during surveillance or after chemotherapy were collected from the literature. A survey of urologists was conducted to evaluate the toxicity of first-line and second-line chemotherapy. Using the decision analysis model, chemotherapy exposure of the risk-adapted treatment and surveillance strategies were compared based on this series of clinical utilities. One-way and two-way tests were applied to check the feasibility. RESULTS: In the base case decision analysis of CS1 pediatric testicular cancer, risk-adapted treatment resulted in a lower exposure to chemotherapy than surveillance (average: 0.7965 cycles verse 1.3419 cycles). The sensitivity analysis demonstrated that when the relapse rate after primary chemotherapy was ≤ 0.10 and the relapse rate of the high-risk group was ≥ 0.40, risk-adapted treatment would result in a lower exposure to chemotherapy, without any association with the proportion of low-risk patients, the relapse rate of the low-risk group, the relapse rate after salvage chemotherapy or the toxicity utility of second-line chemotherapy compared to first-line chemotherapy. CONCLUSIONS: Based on the decision analysis, risk-adapted treatment might decrease chemotherapy exposure for these high-risk patients, and an evaluation after orchiectomy was critical to this process. Additional clinical studies are needed to validate this statement.


Subject(s)
Antineoplastic Agents/therapeutic use , Chemotherapy, Adjuvant/methods , Neoplasms, Germ Cell and Embryonal/drug therapy , Testicular Neoplasms/drug therapy , Child , Decision Support Techniques , Humans , Male , Neoplasm Recurrence, Local , Neoplasm Staging , Neoplasms, Germ Cell and Embryonal/pathology , Neoplasms, Germ Cell and Embryonal/surgery , Orchiectomy/adverse effects , Orchiectomy/methods , Testicular Neoplasms/pathology , Testicular Neoplasms/surgery , Treatment Outcome
3.
Curr Med Sci ; 40(5): 871-878, 2020 Oct.
Article in English | MEDLINE | ID: mdl-33123902

ABSTRACT

Although the advent of tyrosine kinase inhibitors (TKIs) has dramatically improved the survival of patients with chronic myeloid leukaemia (CML), acquired drug resistance and TKI-insensitive leukaemic stem cells (LSCs) remain major obstacles to a CML cure. In recent years, the reprogramming of mitochondrial metabolism has emerged as a hallmark of cancers, including CML, and in turn may be exploited for therapeutic purposes. Here, we investigated the effects of several drugs on the mitochondrial function of the CML cell line K562 and found that 5-aminoimidazole-4-carboxamide ribotide (AICAR) and decitabine could effectively increase the ATP content and mitochondrial biogenesis. In addition, these two drugs induced cell cycle arrest and a decrease in colony-forming capacity and promoted K562 cell differentiation. Moreover, we demonstrated that treatment with AICAR or decitabine enhanced the sensitivity of K562 cells to imatinib, as evidenced by a combination treatment assay. Altogether, our findings indicate that TKIs combined with mitochondrial regulation may provide a therapeutic strategy for the treatment of CML.


Subject(s)
Aminoimidazole Carboxamide/analogs & derivatives , Fusion Proteins, bcr-abl/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Mitochondria/drug effects , Ribonucleotides/pharmacology , Aminoimidazole Carboxamide/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Decitabine/pharmacology , Drug Resistance, Neoplasm/drug effects , Fusion Proteins, bcr-abl/antagonists & inhibitors , Humans , Imatinib Mesylate/pharmacology , K562 Cells , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Mitochondria/genetics , Protein Kinase Inhibitors/pharmacology
4.
BMC Urol ; 19(1): 131, 2019 Dec 10.
Article in English | MEDLINE | ID: mdl-31823766

ABSTRACT

BACKGROUND: The presence of urinary fistula after ileal conduit urinary diversion is a challenging complication, and this study investigated the role of the intra-conduit negative pressure system (NPS) in the presence of urinary fistula following ileal conduit (IC) urinary diversion as a conservative treatment. METHODS: Using the intra-conduit NPS, a minor drainage tube was placed within a silicon tube to suck urine from the conduit with consistent negative pressure. Patients with urinary fistula following IC from August 2012 to July 2017 were recorded, and the clinical characteristics and outcome were retrospectively analyzed. RESULTS: The intra-conduit NPS was used as a primarily conservative treatment for 13 patients who suffered from urinary fistula and presented with a large amount of abdominal/pelvic drainage without other significant morbidities. The median age was 60 years old (42-74 years), and 7patients were male. The median duration between the IC operation and the presence of urinary fistula was 15 days (2-28 days), and elevated creatinine levels were detected in the abdominal/pelvic drainage with a median level of 2114 µmol/L (636-388 µmol/L). A significant decrease in abdominal/pelvic drainage was identified in 12 patients. The median time that the NPS was used was 9 days (7-11 days). The other patient did not show any improvements after 2 days of observation and then underwent open surgery. With ureteral stenting, 2 abdominal drainage tubes and the intra-conduit NPS were placed during operation, no urine leakage was observed in the abdominal/pelvic field, and the patient was cured in 9 days. With a median follow-up of 22 months, no fistula recurrence or hydronephrosis was detected. CONCLUSION: The intra-conduit negative pressure system is a feasible and promising way to cure urinary fistula following ileal conduit urinary diversion. Because this procedure is a mini-invasive and simple approach, it might represent an alternative in selected patients.


Subject(s)
Conservative Treatment/methods , Drainage/methods , Postoperative Complications/therapy , Urinary Diversion/adverse effects , Urinary Fistula/therapy , Adult , Aged , Anastomosis, Surgical/methods , Creatinine/blood , Drainage/instrumentation , Female , Humans , Male , Middle Aged , Postoperative Complications/blood , Retrospective Studies , Stents , Urinary Fistula/blood
5.
Cancer Sci ; 110(9): 2822-2833, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31278883

ABSTRACT

Kinesin family member C1 (KIFC1) is implicated in the clustering of multiple centrosomes to maintain tumor survival and is thought to be an oncogene in several kinds of cancers. In our experiments, we first performed bioinformatics analysis to investigate the expression levels of KIFC1 in bladder cancer (BC) specimens and normal bladder epitheliums and then, using our samples, verified findings by quantitative real-time PCR and western blotting assays. All data showed that KIFC1 was significantly upregulated in BC specimens at both the mRNA and protein levels. Immunohistochemical studies in a cohort of 152 paraffin-embedded BC tissues displayed that upregulated expression of KIFC1 clearly correlated with pT status (P = .014) and recurrent status (P = .002). Kaplan-Meier survival analysis and log-rank test indicated that patients with BC with high KIFC1 expression had both shorter cancer-specific survival (P < .001) and recurrence-free survival time (P < .001) than those with low KIFC1 expression. Furthermore, ectopic downregulation of KIFC1 weakened BC cell proliferation and migration both in vitro and in vivo, whereas upregulation of KIFC1 enhanced this in vitro. Overexpression of KIFC1 phosphorylated GSK3ß and promoted Snail through activating AKT (protein kinase B0) to induce proliferation and epithelial-mesenchymal transition (EMT) and, therefore, substantially promoted BC migration and metastasis. Our study revealed an oncogenic role for KIFC1 to promote BC cell proliferation and EMT via Akt/GSK3ß signaling; KIFC1 might be a promising prognostic biomarker as well as a therapeutic target for BC.


Subject(s)
Biomarkers, Tumor/metabolism , Epithelial-Mesenchymal Transition , Glycogen Synthase Kinase 3 beta/metabolism , Kinesins/metabolism , Neoplasm Recurrence, Local/diagnosis , Urinary Bladder Neoplasms/pathology , Animals , Cell Line, Tumor , Cell Proliferation , Disease-Free Survival , Female , Humans , Kaplan-Meier Estimate , Male , Mice , Mice, Nude , Middle Aged , Neoplasm Recurrence, Local/pathology , Neoplasm Staging , Phosphorylation , Prognosis , Proto-Oncogene Proteins c-akt/metabolism , Snail Family Transcription Factors/metabolism , Up-Regulation , Urinary Bladder/pathology , Urinary Bladder Neoplasms/mortality , Urothelium/pathology , Xenograft Model Antitumor Assays
6.
Huan Jing Ke Xue ; 40(3): 1217-1221, 2019 Mar 08.
Article in Chinese | MEDLINE | ID: mdl-31087968

ABSTRACT

Microplastics are tiny ubiquitous plastic particles smaller than five millimeters (5 mm) in size. Coastal and bay areas are constantly under continuous and increasing pressure from the activities of humans. Microplastic pollution is now recognized as a great threat to these areas. This study was designed to understand the microplastic pollution of the beaches in Xiamen Bay. The results showed that microplastic abundance was from (28.1±9.4) to (312.7±35.2) n·kg-1. Four main types of microplastics were identified in Xiamen Bay, including fragments, foams, thin films, and fibers. Of the particles analyzed, over 80% were predominantly microplastic fragments and foam, while the films and fiber microplastics accounted for less than 20% of the particles. Studies on the particle size of microplastics also indicated that the microplastics with particle size less than 1 mm accounted for over 60% of the total microparticles, and the abundance of microplastics trend to decrease with increase in the particle size. Fourier transform infrared spectroscopy analysis demonstrated that the major component of the fragments and fibers was identified as polyethylene, and that of foams and films was identified as polystyrene. The scanning electron microscope studies showed that the microplastics presented obvious signs of cracks. In general, Xiamen Bay beach microplastic pollution is at a lower middle level, and land source pollution is the main source of the microplastic pollution.

7.
Zhonghua Yi Shi Za Zhi ; 39(2): 104-7, 2009 Mar.
Article in Chinese | MEDLINE | ID: mdl-19824373

ABSTRACT

Clinical Diary was the only medical book of PANG Shiwan, Guangxi traditional Chinese medical doctor in the Republic Period of China. The book has never been published and the manuscript and is now in the collection of Guiling library. This book has 115 dated entries divided into 9 volumes with about 100,000 characters; it has vivid local medical characteristics displaying the comprehensive medical skill and reflecting the matter-of-fact scientific spirit of the author. This book contains some treatment experiences of emergent and severe syndromes and has certain clinical guiding values. The bibliography of Clinical Diary has some errors and ought to be corrected.


Subject(s)
Manuscripts, Medical as Topic/history , Medicine, Chinese Traditional/history , China , History, 20th Century
8.
Clin Exp Pharmacol Physiol ; 35(1): 7-10, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17941896

ABSTRACT

1. Recent studies indicate that the aquaporin-1 (AQP1) water channel is expressed in human and equine articular chondrocytes. The role of AQP1 in chondrocyte function has not been characterized. In the present study, we investigated the expression of the AQP1 water channel in cultured articular chondrocytes from wild-type (AQP1(+/+)) and AQP1-knockout (AQP1(-/-)) mice and characterized its function in chondrocyte proliferation, migration and adhesion. 2. Expression of AQP1 mRNA and protein was identified in freshly isolated neonatal AQP(+/+) chondrocytes. Immunofluorescence localized the AQP1 protein to the plasma membrane of AQP(+/+) chondrocytes in primary cultures. Relative plasma membrane water permeability of AQP1(+/+) chondrocytes was approximately 1.6-fold higher than that of AQP1(-/-) chondrocytes. 3. The chondrocyte proliferation rate was not affected by AQP1 deletion. However, the serum-induced transwell migration rate of AQP1(-/-) chondrocytes was markedly reduced compared with AQP1(+/+) chondrocytes (16.2 +/- 0.2 vs 27.1 +/- 0.3%, respectively; P < 0.01). Cell adhesion to type II collagen-coated plates was also significantly reduced in AQP1(-/-) chondrocytes compared with AQP1(+/+) chondrocytes (38.1 +/- 0.3 vs 51 +/- 1%, respectively; P < 0.01). 4. The results provided direct evidence that AQP1-mediated plasma membrane water permeability plays an important role in chondrocyte migration and adhesion.


Subject(s)
Aquaporin 1/metabolism , Cartilage, Articular/metabolism , Cell Adhesion , Cell Membrane Permeability , Cell Membrane/metabolism , Cell Movement , Chondrocytes/metabolism , Water/metabolism , Animals , Aquaporin 1/deficiency , Aquaporin 1/genetics , Cartilage, Articular/cytology , Cell Proliferation , Cells, Cultured , Chondrogenesis , Collagen Type II/metabolism , Mice , Mice, Transgenic , RNA, Messenger/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...